v3.25.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Operating expenses:        
Research and development $ 261,499 $ 21,823 $ 288,200 $ 46,145
General and administrative 12,785 7,212 19,375 15,216
Total operating expenses 274,284 29,035 307,575 61,361
Loss from operations (274,284) (29,035) (307,575) (61,361)
Other income (expense):        
Interest income 537 1,196 1,342 2,718
Change in fair value of warrant liabilities (1,299,922) 0 (1,299,922) 0
Total other (expense) income (1,299,385) 1,196 (1,298,580) 2,718
Net loss $ (1,573,669) $ (27,839) $ (1,606,155) $ (58,643)
Net loss per share attributable to common stockholders, basic $ (12.56) $ (0.41) $ (12.84) $ (0.86)
Net loss per share attributable to common stockholders, diluted $ (12.56) $ (0.41) $ (12.84) $ (0.86)
Weighted-average common shares outstanding, basic 125,271,447 68,299,170 125,049,032 68,165,068
Weighted-average common shares outstanding, diluted 125,271,447 68,299,170 125,049,032 68,165,068
Other comprehensive income (loss):        
Unrealized (loss) gain on available for sale marketable securities $ (9) $ 17 $ (8) $ 7
Total other comprehensive (loss) income: (9) 17 (8) 7
Comprehensive loss $ (1,573,678) $ (27,822) $ (1,606,163) $ (58,636)